Loading…

Unraveling HIV-1 diagnosis in special pediatric cases

•There are still several cases of late diagnoses in HIV-1 infected infants.•"Special pediatric cases" have discordant virologic results between their samples.•"Special pediatric cases" represent a challenge in early infant HIV-1 diagnosis. Early HIV-1 diagnosis and initiation of...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical virology 2020-10, Vol.131, p.104343-104343, Article 104343
Main Authors: Golemba, Marcelo. D., Mecikovsky, Débora, Ortíz de Zárate, Marcela, Silva, Gustavo, Aulicino, Paula C., Pineda, María, Taicz, Moira, Rossi, Verónica, Bologna, Rosa, Mangano, Andrea M.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•There are still several cases of late diagnoses in HIV-1 infected infants.•"Special pediatric cases" have discordant virologic results between their samples.•"Special pediatric cases" represent a challenge in early infant HIV-1 diagnosis. Early HIV-1 diagnosis and initiation of antiretroviral treatment is essential to prevent AIDS, and reduce mortality in children. HIV-1 molecular diagnosis in children before 18 months of age require, two independent samples to confirm a result. However, some patients have discordant virologic results in different samples, raising uncertainty for a conclusive diagnosis. We defined these patients as “special pediatric cases”. The aim of our study was to characterize the “special pediatric cases” among HIV-1 infected children diagnosed in a five-year period at our laboratory and evaluate the impact on the time to HIV-1 diagnosis. A total of 44 perinatally HIV-1 infected infants with molecular diagnostic performed at the Pediatric Garrahan Hospital were analyzed from 2013 to 2017. We identified eight “special pediatric cases”. In the first samples, all of them had negative results by different DNA-PCR assays. Three infants had undetectable plasma viral load (pVL), four had low detectable pVL value, and one infant had no available pVL. All samples with detectable pVL, including those with low pVL (ie: 65copies/mL), had high pVL values at the end of the diagnosis. Considering the age of the HIV-1 infected children at the end of the diagnosis, five “special pediatric cases” (62 %) had a “late” positive diagnosis [mean (range) = 146 (89–268) days old]. These "special pediatric cases" are not as unusual as previously thought and are important diagnostic challenges. Also, this study add evidence to include the viral load assay in the molecular diagnostic algorithm for perinatal HIV-1 infection.
ISSN:1386-6532
1873-5967
DOI:10.1016/j.jcv.2020.104343